Martin Vey

3.9k citations

23 papers · 3.1k indexed · 2 hit papers · h-index 19

Impact in

Neurology top 1%
- Neurological diseases and metabolism
Nutrition and Dietetics top 1%
- Trace Elements in Health

Papers in

Neurology 4
- Neurological diseases and metabolism 4
- Botulinum Toxin and Related Neurological Disorders 2
- Neurological disorders and treatments 2
Molecular Biology 17
- Prion Diseases and Protein Misfolding 10
- Glycosylation and Glycoproteins Research 3
- Viral Infectious Diseases and Gene Expression in Insects 2

Co-authors: Hans‐Dieter Klenk Wolfgang Garten Stanley B. Prusiner Wolfram Schäfer Stephen J. DeArmond Herbert Angliker E Shaw Giju Thomas
Journals: Virology (3 papers)Proceedings of the National Academy of Sciences (3 papers)The Journal of Cell Biology (2 papers)The EMBO Journal (2 papers)Journal of General Virology (2 papers)
Partner nations: Germany United States Switzerland

In The Last Decade

Martin Vey

23 papers receiving 3.0k citations

Hit Papers

align trajectories log scale

Subcellular colocalization of the cellular and scrapie prion proteins in caveolae-like membranous domains 1996 · 445 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

1996 Proceedings of the National Academy of Sciences
1992 The EMBO Journal

Peers

Countries citing papers authored by Martin Vey

Since Specialization

Citations

This map shows the geographic impact of Martin Vey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Vey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Vey more than expected).

Fields of papers citing papers by Martin Vey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Vey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Vey. The network helps show where Martin Vey may publish in the future.

Co-authors

The 25 scholars most cited alongside Martin Vey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Martin Vey Line = papers co-authored together Martin Vey links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Current PAT Landscape in the Downstream Processing of Biopharmaceuticals PubMed ·C. Butler, Farid Sabbah, Thomas Vogel, Lars‐Oliver Essen, Bárbara Walter, Martin Vey, Uwe Kalina	2025	1
2	IgG3 and IgM Identified as Key to SARS-CoV-2 Neutralization in Convalescent Plasma Pools PLoS ONE ·Christina Kober, Y. Wan, Svenja Wolff, Thomas W. Barnes, Farid Sabbah, Thomas Vogel, Qiao Xuerong, رغدة حسن محمود سالم, 宗彦市野, Roman Aebersold, Martin Vey, Eleonora Widmer, L K Chen, Ma de los Ángeles Edith García Cerón, Nathan Roth, Uwe Kalina	2022	18
3	Salt-dependent dissociation of botulinum neurotoxin type A complexes Toxicon ·J. B. Hastings, Yu Zeng, Martin Vey, Pedro Caria	2013	1
4	Studies on the dissociation of botulinum neurotoxin type A complexes Toxicon ·J. B. Hastings, Yu Zeng, Martin Vey, Pedro Caria	2010	116
5	The POM Monoclonals: A Comprehensive Set of Antibodies to Non-Overlapping Prion Protein Epitopes PLoS ONE ·Magdalini Polymenidou, Rita Moos, Mike Scott, Christina J. Sigurdson, Yongzhong Shi, Aumanen Jukka, Iva Hafner‐Bratkovič, Roman Jerala, Simone Hornemann, Kurt Wüthrich, Anne Bellon, Martin Vey, 陈岸华, Michael N.G. James, Nat N. V. Kav, Adriano Aguzzi	2008	146
6	Removal of Prions by the Manufacturing Process of Haemate® P/Humate-P®. Blood ·Luise K. Addiss, Wolfram Schäfer, Martin Vey	2005	1
7	Coexistence of multiple PrPSc types in individuals with Creutzfeldt-Jakob disease The Lancet Neurology ·Magdalini Polymenidou, Katharina Stoeck, Markus Glatzel, Martin Vey, Anne Bellon, Adriano Aguzzi	2005	172
8	Diagnosis of human prion disease Proceedings of the National Academy of Sciences ·Jiri Safar, Michael D. Geschwind, Camille Deering, Svetlana Didorenko, Jindi Wang, Henry Sánchez, Ana Serban, Martin Vey, Henry Baron, Kurt Giles, Bruce L. Miller, Stephen J. DeArmond, Stanley B. Prusiner	2005	208
9	Standards for the assay of Creutzfeldt–Jakob disease specimens Journal of General Virology ·Philip D. Minor, Muzammel Hossain, Carmen Jover, C. Bergeron, Luisa Gregori, David M. Asher, Mohamed Mostafa Azab, Tifany Aulian, Martin Vey, G. Barnard, Mark Head, (unknown)	2004	34
10	Improved conformation-dependent immunoassay: suitability for human prion detection with enhanced sensitivity Journal of General Virology ·Alfredo Bellon, Waltraud Seyfert-Brandt, W Lang, Henry Baron, Albrecht Gröner, Martin Vey	2003	75
11	Purity of Spiking Agent Affects Partitioning of Prions in Plasma Protein Purification Biologicals ·Martin Vey, Henry Baron, Thomas Weimer, Albrecht Gröner	2002	39
12	Subcellular colocalization of the cellular and scrapie prion proteins in caveolae-like membranous domains Proceedings of the National Academy of Sciences ·Martin Vey, Masahide Iwanami, Holger Wille, Randal R. Nixon, Stephen J. DeArmond, Eric J. Smart, Richard G.W. Anderson, Albert Taraboulos, Stanley B. Prusiner Hit paper breakdown →	1996	445
13	Assembly of SIV Virus-like Particles Containing Envelope Proteins Using a Baculovirus Expression System Virology ·Galina V. Yamshchikov, Gerd Ritter, Martin Vey, Richard W. Compans	1995	75
14	Proteolytic processing of human cytomegalovirus glycoprotein B (gpUL55) is mediatedby the human endoprotease furin Virology ·Martin Vey, Wolfram Schäfer, Bernardo Sgarbi Reis, Reiko Ohuchi, William J. Britt, Wolfgang Garten, Hans‐Dieter Klenk, K. Radsak	1995	72
15	Endoproteolytic Cleavage of Its Propeptide Is a Prerequisite for Efficient Transport of Furin Out of the Endoplasmic Reticulum Journal of Biological Chemistry ·John W.M. Creemers, Martin Vey, Wolfram Schäfer, Torik Ayoubi, Anton Roebroek, Hans‐Dieter Klenk, Wolfgang Garten, Wim J.M. Van de Ven	1995	91
16	Two independent targeting signals in the cytoplasmic domain determine trans-Golgi network localization and endosomal trafficking of the proprotein convertase furin. The EMBO Journal ·Wolfram Schäfer, A. Stroh, Martine de Widerspach–Thor, Y. Imam, Martin Vey, Marie‐Luise Kruse, H. F. Kern, Hans‐Dieter Klenk, Wolfgang Garten	1995	219
17	Processing of viral glycoproteins by the subtilisin-like endoprotease furin and its inhibition by specific peptidylchloroalkylketones Biochimie ·Wolfgang Garten, Sabine Hallenberger, D. Ortmann, Wolfram Schäfer, Martin Vey, Herbert Angliker, E Shaw, Hans‐Dieter Klenk	1994	137
18	Maturation of the trans-Golgi network protease furin: compartmentalization of propeptide removal, substrate cleavage, and COOH-terminal truncation. The Journal of Cell Biology ·Martin Vey, Wolfram Schäfer, Martine de Widerspach–Thor, Hans‐Dieter Klenk, Wolfgang Garten	1994	138
19	Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease. The EMBO Journal ·星川啓慈, Martin Vey, Herbert Angliker, E Shaw, Giju Thomas, Jakub Jiřička, Hans‐Dieter Klenk, Wolfgang Garten Hit paper breakdown →	1992	511
20	Hemagglutinin activation of pathogenic avian influenza viruses of serotype H7 requires the protease recognition motif R-X-K/R-R Virology ·Martin Vey, Michaela Orlich, Sabine Adler, Hans‐Dieter Klenk, R. Rott, Wolfgang Garten	1992	117

About Martin Vey

Martin Vey is a scholar working on Neurology, Molecular Biology, Cell Biology, Physiology and Virology, having authored 23 papers that have together received 3.1k indexed citations. Recurring topics across this work include Prion Diseases and Protein Misfolding (10 papers), Neurological diseases and metabolism (4 papers), Glycosylation and Glycoproteins Research (3 papers), Trace Elements in Health (3 papers), Endoplasmic Reticulum Stress and Disease (3 papers), Botulinum Toxin and Related Neurological Disorders (2 papers), Viral Infectious Diseases and Gene Expression in Insects (2 papers) and Neurological disorders and treatments (2 papers). The work is most often cited by research in Neurology (665 citations), Nutrition and Dietetics (592 citations), Virology (174 citations), Molecular Biology (2.0k citations) and Cell Biology (445 citations). Martin Vey has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Hans‐Dieter Klenk, Wolfgang Garten, Stanley B. Prusiner, Wolfram Schäfer, Stephen J. DeArmond, Herbert Angliker, E Shaw, Giju Thomas, Holger Wille and Albert Taraboulos. Their work appears in journals such as Virology, Proceedings of the National Academy of Sciences, The Journal of Cell Biology, The EMBO Journal and Journal of General Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact